Other Information
−Removed: Exhibit Number
Description of Exhibit
−Removed: OptimizeRx Corporation 2022 Cash Bonus Plan.
−Removed: Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 4, 2022.
−Removed: Amendment to Employment Agreement by and between the Company and Stephen Silvestro dated February 28, 2022.
−Removed: Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 4, 2022.
−Removed: Amendment to Employment Agreement by and between the Company and Marion Odence-Ford dated February 28, 2022.
−Removed: Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on March 4, 2022.
Certification of Chief Executive Officer pursuant to 18 U.S.C.
11 unchanged sentences
** Provided herewith
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934,
−Removed: the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
+Added: Pursuant to the requirements of the Securities
+Added: Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OptimizeRx Corporation
+Added: August 9, 2022
/s/ William J.
2 unchanged sentences
OptimizeRx Corporation
+Added: August 9, 2022
/s/ Edward Stelmakh
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.